IM Cannabis (IMCC) Other Accumulated Expenses (2023 - 2026)

IM Cannabis' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 37.33% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 37.33% YoY), while the FY2025 annual figure was $4.4 million, up 19.22% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $3.8 million, down from $4.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $10.1 million in Q3 2025, with the low at $3.6 million in Q4 2024.
• The 4-year median for Other Accumulated Expenses is $4.6 million (2023), against an average of $5.5 million.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses advanced 21.65% in 2025, then slumped 37.33% in 2026.
• IM Cannabis' Other Accumulated Expenses stood at $4.6 million in 2023, then slipped by 21.62% to $3.6 million in 2024, then gained by 21.65% to $4.4 million in 2025, then fell by 12.98% to $3.8 million in 2026.
• Business Quant data shows IMCC's Other Accumulated Expenses at $3.8 million in Q1 2026, $4.4 million in Q4 2025, and $10.1 million in Q3 2025.